Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filings

Form Description Filing date View
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
8-K/A

Amendment to a previously filed 8-K

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML